oscar health inc - OSCR
OSCR
Close Chg Chg %
14.85 0.09 0.57%
Closed Market
14.94
+0.09 (0.57%)
Volume: 2.90M
Last Updated:
Dec 24, 2025, 12:59 PM EDT
Company Overview: oscar health inc - OSCR
OSCR Key Data
| Open $14.80 | Day Range 14.67 - 15.02 |
| 52 Week Range 11.20 - 23.75 | Market Cap $3.93B |
| Shares Outstanding 264.68M | Public Float 210.67M |
| Beta 1.88 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.95 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 8.93M |
OSCR Performance
| 1 Week | 0.20% | ||
| 1 Month | -16.92% | ||
| 3 Months | -18.95% | ||
| 1 Year | 8.19% | ||
| 5 Years | N/A |
OSCR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 15.111 | |
| Number of Ratings | 11 | Current Quarters Estimate | -0.895 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | -1.271 | |
| Last Quarter’s Earnings | -0.53 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.10 | Next Fiscal Year Estimate | -0.094 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 8 | 10 | 11 |
| Mean Estimate | -0.89 | 0.63 | -1.27 | -0.09 |
| High Estimates | -0.74 | 1.19 | -1.07 | 0.44 |
| Low Estimate | -1.07 | 0.36 | -1.42 | -0.94 |
| Coefficient of Variance | -10.62 | 43.97 | -8.45 | -426.32 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 3 | 3 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 4 | 4 | 4 |
| MEAN | Hold | Underweight | Underweight |
SEC Filings for Oscar Health Inc - OSCR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Oscar Health Inc - OSCR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 15, 2025 | Jeffery H. Boyd Director | 57,207 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | David Plouffe Director | 1,734 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | William J. Gassen Director | 1,530 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | 2,866,666 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2025 | Janet Liang President, Oscar Insurance | 97,402 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Janet Liang President, Oscar Insurance | 147,637 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Adam McAnaney Chief Legal Officer | 123,376 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Adam McAnaney Chief Legal Officer | 185,004 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |